Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most adults who meet the clinical criteria, Mounjaro delivers meaningful, sustained weight loss that other methods haven't matched — clinical trials recorded average body-weight reductions of around 20% at the highest dose over 72 weeks. That said, whether Mounjaro is worth it for you depends on your health picture, your expectations and the quality of support around your treatment. It is a prescription-only medicine, so a prescriber assesses whether it is clinically appropriate before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starting point for any 'is it worth it' question is what tirzepatide actually does in controlled conditions. The SURMOUNT-1 trial (published in the New England Journal of Medicine) followed 2,539 adults with obesity over 72 weeks. Those on the 15 mg dose lost an average of roughly 20–21% of their starting body weight. That is a substantial figure by any clinical benchmark. Head-to-head data from SURMOUNT-5 (2025) showed tirzepatide producing greater average weight reduction than semaglutide 2.4 mg over the same period.
These are averages. Some people lose more; some less. The trial participants also followed a reduced-calorie diet and increased their activity, which matters when you are setting your own expectations. Mounjaro reduces appetite markedly for most people, which makes those lifestyle changes considerably easier to sustain, but the medicine works alongside them, not instead of them. You can read the background on what Mounjaro is and how it works if you want the mechanism before the numbers.
One thing the evidence does not show: results that stick permanently after you stop. Weight management is a long-term conversation between you, the medicine and a prescriber who knows your case.
Private Mounjaro costs vary by dose and provider. Since Eli Lilly adjusted UK list pricing in September 2025, the market for higher doses typically sits anywhere from roughly £149 to £375 per month depending on strength and where you get it, figures that have been widely reported. On our Mounjaro treatment page you can see current pricing for each dose.
The question worth asking is not 'what is the lowest number I can find online' but 'what does that number actually include?' Some headline prices strip out the prescription fee, the clinical consultation, delivery and any follow-up support. A transparent price that covers all of those is a better comparison than a bare pen price that does not. For a fuller breakdown of what drives private treatment costs, the weight-loss treatments overview sets out what a complete private service looks like.
Timing matters in practice too. Orders placed before 12pm on a weekday go out the same day once approved, so if you are thinking about starting around payday or want treatment in hand before a busy period, that window is worth planning around.
Mounjaro is licensed in the UK for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present, such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone, though, is not the whole picture. A prescriber also looks at your medical history, current medications and whether any contraindications apply.
There are situations where tirzepatide is not appropriate: pregnancy, breastfeeding, or actively trying to conceive; under-18s; a personal or family history of medullary thyroid carcinoma or MEN2 syndrome. People using oral contraceptives need to know that absorption of the pill can be reduced during the first four weeks of treatment and after each dose increase, so a backup contraceptive method is recommended during those windows. If you are also prescribed a stimulant medication, our page on taking Mounjaro alongside Elvanse covers what you need to know about using both together. The tirzepatide overview covers these safety considerations in more detail.
Side effects are worth factoring in honestly. Nausea, loose stools and indigestion are common, especially after starting or moving up a dose. They are not usually severe, and for most people they settle. The NHS tirzepatide medicines page lists the full side-effect profile with guidance on when to seek help. A question our prescribers hear regularly: 'Will I feel awful for weeks?' The honest answer is that many people feel some GI discomfort in the first week or two, then find it manageable.
Clinical efficacy and cost are two legs of the decision. The third is your own definition of success. For some people, the value is a 10–15% weight reduction that brings blood pressure or blood sugar into a healthier range. For others, it is reaching a BMI that opens up surgical or fertility options. Both are legitimate.
What Mounjaro is not: a short course with permanent results, or a medicine that works without any lifestyle engagement. The people who get the most from it tend to use the appetite suppression it creates to build genuinely different eating habits, not just eat less of the same things. If you want to understand how Mounjaro is taken week to week, including injection technique and timing, that is worth reading before you start. If you have come across the name tirzepatide and are unsure whether tirzepatide and Mounjaro are the same thing, that page explains the relationship clearly. And if you are exploring how tirzepatide fits into the broader range of weight-loss options, comparing the full picture makes sense before committing.
A realistic framing: for people who meet the clinical criteria and approach it with the right expectations, the evidence consistently supports Mounjaro as the most effective weight-loss medicine currently licensed in the UK. Whether that makes it worth it is a question that belongs in a consultation, with a prescriber who can apply that evidence to your specific situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.